The companies will work together to incorporate Sites Medical’s OsteoSync Ti technology into Conformis’ cementless total knee replacement products going forward, the release said. OsteoSync Ti technology is a porous titanium bone ingrowth material and has been used in more than 50,000 procedures since it was introduced for clinical use in 2014.
“We are excited to be partnering with Conformis, a company that has brought a high degree of innovation to the joint replacement field,” Greg Stalcup, president and CEO of Sites Medical said in the release. “We look forward to working with the Conformis team to combine our respective technologies to deliver new generations of high performance, cost effective, and OR-efficient products to the market.”
More articles on devices:
Spine surgeon, inventor files patent infringement suit against NuVasive
14 key thoughts on bundled payments in spine surgery
Flexibility, patience & financial stability — 5 spine surgeons on lessons learned in 2020
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.